首页|期刊导航|Bone Research|Novel therapeutic strategies for osteoarthritis:from mechanistic insights to precision medicine

Novel therapeutic strategies for osteoarthritis:from mechanistic insights to precision medicineOA

中文摘要

Osteoarthritis(OA)is a prevalent chronic degenerative joint disease that significantly impacts the quality of life for over 500 million individuals affected.OA is increasingly recognized as a whole-joint disorder characterized by complex biochemical and cellular changes across various joint tissues.However,traditional approaches such as nonsteroidal anti-inflammatory drugs(NSAIDs)and corticosteroids often fall short in halting disease progression or restoring joint function.Thereby,recent innovations in OA management are focused on underlying pathophysiology,driving the development of regenerative therapies,targeted antiinflammatory agents and senolytic or senomorphic approaches.Accordingly,this paper reviews current progress in these areas by integrating evidence from clinical and pre-clinical studies to clarify therapeutic limitations,unresolved mechanistic and phenotypic gaps and the emerging strategies required to advance disease-modifying therapy in OA.It further outlines pathways toward precision,phenotype-aligned interventions,an integration that current literature has not yet consolidated.

Muhammad Umar;Ziling Wang;Jingwen Li;Zhen Li;Gang Li;Liping Tong;Di Chen

Faculty of Pharmaceutical Sciences,Shenzhen University of Advanced Technology,Shenzhen,China Center for AI-Driven Medical Research,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen,ChinaFaculty of Pharmaceutical Sciences,Shenzhen University of Advanced Technology,Shenzhen,China Center for AI-Driven Medical Research,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen,ChinaFaculty of Pharmaceutical Sciences,Shenzhen University of Advanced Technology,Shenzhen,China Center for AI-Driven Medical Research,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen,ChinaAO Research Institute Davos,Davos,SwitzerlandInstitute of Biomedicine and Biotechnology,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen,ChinaCenter for AI-Driven Medical Research,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen,ChinaFaculty of Pharmaceutical Sciences,Shenzhen University of Advanced Technology,Shenzhen,China Center for AI-Driven Medical Research,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen,China

医药卫生

targeted anti inflammatory agentsbiochemical cellular changesosteoarthritischronic degenerative joint diseasemechanistic insightsregenerative therapiessenolytic approachesprecision medicine

《Bone Research》 2026 (3)

P.723-741,19

supported by the National Key Research and Development Program of China(2022YFA1207500)to D.CShenzhen Medical Research Fund B2502005 to D.Csupported by the Natural Science Foundation of China(NSFC)grant(82394445)to D.CShenzhen Science and Technology Research Fund(JCYJ20220818101414032)to L.T.

10.1038/s41413-026-00540-6

评论